- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Developing Strategies to Drive Value in Mental Health Care, Part 3
Leadership from the Innovation & Value Initiative, along with experts in mental health and a representative from employer purchasing group, discuss strategies for creating value-based decisions in mental health coverage.
In the latest Matters in Managed Care webinar, experts discussed the current state of mental health care, including the growing consensus on the need for change, strategies to provide high value care, and opportunities for collaboration among payers and other healthcare stakeholders.
The speakers highlighted common challenges for employers and payers regarding coverage for mental health care; discussed common definitions of value for payers, employers, and people with lived experience; shared strategies to incentivize high-value interventions for mental health care; and identified opportunities for future collaboration.
The speakers were:
- Schroeder Stribling, MSW, president and CEO, Mental Health America
- Michael Thompson, president and CEO, National Alliance of Healthcare Purchaser Coalitions
- Jennifer Bright, MPA, executive director, Innovation and Value Initiative
- Kevin Ronneberg, MD, vice president and associate medical director, HealthPartners
In segment 3, they discussed existing incentives in mental health care and whether or not they make sense.
Personalizing MPN Disease Management and Monitoring
January 1st 2025The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center.
Read More
AI in Oncology: Opportunities and Challenges for NSCLC
January 1st 2025Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence (AI) in oncology, while cautioning against its limitations, including the risk of unsupported recommendations.
Read More
